Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maher

Showing results (1041-1050 of 1,158) with videos related to

Pageof 116
Sort By:
The European Respiratory Journal|January 26, 2020
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extentRachele Invernizzi, Joseph Barnett, Bhavin Rawal, et al.
Annals of the American Thoracic Society|May 9, 2023
The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE StudyPeter Saunders, Zhe Wu, William A Fahy, et al.
Lung|July 30, 2025
Stratifying GAP Stages by MUC5B rs35705950 T-Allele Carriage Refines Survival Prediction in IPFJoanne J van der Vis, Antje Prasse, Elisabetta A Renzoni, et al.
Toxins|September 22, 2022
Arabic Gum Could Alleviate the Aflatoxin B<sub>1</sub>-provoked Hepatic Injury in Rat: The Involvement of Oxidative Stress, Inflammatory, and Apoptotic PathwaysNoha Ahmed, Samir M El-Rayes, Waleed F Khalil, et al.
BMJ Open Respiratory Research|December 31, 2021
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA<sub>1</sub>) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)Tamera J Corte, Lisa Lancaster, Jeffrey J Swigris, et al.
The European Respiratory Journal|April 20, 2023
The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation studyCarl J Reynolds, Fabiola Del Greco M, Richard J Allen, et al.
American Journal of Respiratory and Critical Care Medicine|March 29, 2008
Interstitial lung disease in systemic sclerosis: a simple staging systemNicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
The Journal of Rheumatology|February 5, 2013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosisAngelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, et al.
Epilepsia|March 26, 2018
A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsyTalia A Atkin, Chani M Maher, Aaron C Gerlach, et al.
Pageof 116

Showing results (1041-1050 of 1,158) with videos related to

Sort By:
Pageof 116
The European Respiratory Journal|January 26, 2020
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extentRachele Invernizzi, Joseph Barnett, Bhavin Rawal, et al.
Annals of the American Thoracic Society|May 9, 2023
The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE StudyPeter Saunders, Zhe Wu, William A Fahy, et al.
Lung|July 30, 2025
Stratifying GAP Stages by MUC5B rs35705950 T-Allele Carriage Refines Survival Prediction in IPFJoanne J van der Vis, Antje Prasse, Elisabetta A Renzoni, et al.
Toxins|September 22, 2022
Arabic Gum Could Alleviate the Aflatoxin B<sub>1</sub>-provoked Hepatic Injury in Rat: The Involvement of Oxidative Stress, Inflammatory, and Apoptotic PathwaysNoha Ahmed, Samir M El-Rayes, Waleed F Khalil, et al.
BMJ Open Respiratory Research|December 31, 2021
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA<sub>1</sub>) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)Tamera J Corte, Lisa Lancaster, Jeffrey J Swigris, et al.
The European Respiratory Journal|April 20, 2023
The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation studyCarl J Reynolds, Fabiola Del Greco M, Richard J Allen, et al.
American Journal of Respiratory and Critical Care Medicine|March 29, 2008
Interstitial lung disease in systemic sclerosis: a simple staging systemNicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
The Journal of Rheumatology|February 5, 2013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosisAngelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, et al.
Epilepsia|March 26, 2018
A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsyTalia A Atkin, Chani M Maher, Aaron C Gerlach, et al.
Pageof 116